Skip to main content

News of Note—Pfizer, Sanofi Pasteur and more

newspaper
In this week's News of Note, GeoVax teamed with Emory University on a therapeutic HPV vaccine. (Pixabay)

> Pfizer's vaccine sales grew 10% in the second quarter to $1.4 billion. Release

> Sanofi's vaccines sales slipped during the second quarter due to a supply issue in China; timing of government orders for its polio, pertussis and Hib franchise; and a tough year-over-year comparison for Menactra. Release

> GeoVax teamed with Emory University to develop a therapeutic HPV vaccine. Release

> Sanofi cut a phase 2 tuberculosis vaccine from its pipeline. Endpoints News story

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.